DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Nam S, Kim D, Cheng JQ. et al.
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
Cancer Res 2005;
65 (20) 9185-9189
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.